Open access peer-reviewed chapter

Therapeutic Effects of the Sphingosine 1-Phosphate Receptor Modulator, Fingolimod (FTY720), on Experimental Autoimmune Encephalomyelitis

By Kenji Chiba, Hirotoshi Kataoka, Noriyasu Seki and Kunio Sugahara

Submitted: March 30th 2011Reviewed: September 14th 2011Published: February 3rd 2012

DOI: 10.5772/31403

Downloaded: 1697

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Kenji Chiba, Hirotoshi Kataoka, Noriyasu Seki and Kunio Sugahara (February 3rd 2012). Therapeutic Effects of the Sphingosine 1-Phosphate Receptor Modulator, Fingolimod (FTY720), on Experimental Autoimmune Encephalomyelitis, Experimental Autoimmune Encephalomyelitis, Robert Weissert, IntechOpen, DOI: 10.5772/31403. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/experimental-autoimmune-encephalomyelitis-models-disease-biology-and-experimental-therapy/therapeutic-effect-of-the-sphingosine-1-phosphate-receptor-modulator-fingolimod-fty720-on-experiment" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1697total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Effects of Anxiolytic Drugs in Animal Models of Multiple Sclerosis

By Silvia Novío, Manuel Freire-Garabal and María Jesús Núñez-Iglesias

Related Book

First chapter

A Practical Guide to an fMRI Experiment

By Nasser Kashou

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us